Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Horowitz

Showing results (101-110 of 219) with videos related to

Pageof 22
Sort By:
Pharmacogenomics|November 28, 2013
Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in AustraliaMichael J Sorich, John D Horowitz, Wassana Sorich, et al.
International Journal of Cardiology|May 23, 2017
Glycocalyx shedding is markedly increased during the acute phase of Takotsubo cardiomyopathyThanh H Nguyen, Saifei Liu, Gao J Ong, et al.
Cardio-Oncology (London, England)|March 11, 2020
Antecedent cancer in Takotsubo syndrome predicts both cardiovascular and long-term mortalityThanh H Nguyen, Jeanette Stansborough, Gao J Ong, et al.
European Journal of Pharmacology|December 6, 2008
Inhibition of calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide donorsJennifer A Kennedy, Xiang Hua, Kumaril Mishra, et al.
European Journal of Pharmacology|February 21, 2004
Influence of the endothelium on ex vivo tolerance and metabolism of glyceryl trinitrate in rat aortaIvan S de la Lande, Tracey E Siebert, Catherine L Bennett, et al.
Frontiers in Pharmacology|June 9, 2020
Nitroxyl: A Novel Strategy to Circumvent Diabetes Associated Impairments in Nitric Oxide SignalingAnida Velagic, Chengxue Qin, Owen L Woodman, et al.
Cardiovascular Drugs and Therapy|May 22, 2010
Hydralazine does not ameliorate nitric oxide resistance in chronic heart failureYuliy Y Chirkov, Michele De Sciscio, Aaron L Sverdlov, et al.
Journal of the American College of Cardiology|July 6, 2004
The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenonJohn F Beltrame, Stuart P Turner, Sue L Leslie, et al.
Journal of Cardiovascular Pharmacology|November 25, 2005
Dissociation between metabolic and efficiency effects of perhexiline in normoxic rat myocardiumSteven A Unger, Jennifer A Kennedy, Kate McFadden-Lewis, et al.
Journal of the American Heart Association|August 20, 2014
Aging of the nitric oxide system: are we as old as our NO?Aaron L Sverdlov, Doan T M Ngo, Wai P A Chan, et al.
Pageof 22

Showing results (101-110 of 219) with videos related to

Sort By:
Pageof 22
Pharmacogenomics|November 28, 2013
Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in AustraliaMichael J Sorich, John D Horowitz, Wassana Sorich, et al.
International Journal of Cardiology|May 23, 2017
Glycocalyx shedding is markedly increased during the acute phase of Takotsubo cardiomyopathyThanh H Nguyen, Saifei Liu, Gao J Ong, et al.
Cardio-Oncology (London, England)|March 11, 2020
Antecedent cancer in Takotsubo syndrome predicts both cardiovascular and long-term mortalityThanh H Nguyen, Jeanette Stansborough, Gao J Ong, et al.
European Journal of Pharmacology|December 6, 2008
Inhibition of calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide donorsJennifer A Kennedy, Xiang Hua, Kumaril Mishra, et al.
European Journal of Pharmacology|February 21, 2004
Influence of the endothelium on ex vivo tolerance and metabolism of glyceryl trinitrate in rat aortaIvan S de la Lande, Tracey E Siebert, Catherine L Bennett, et al.
Frontiers in Pharmacology|June 9, 2020
Nitroxyl: A Novel Strategy to Circumvent Diabetes Associated Impairments in Nitric Oxide SignalingAnida Velagic, Chengxue Qin, Owen L Woodman, et al.
Cardiovascular Drugs and Therapy|May 22, 2010
Hydralazine does not ameliorate nitric oxide resistance in chronic heart failureYuliy Y Chirkov, Michele De Sciscio, Aaron L Sverdlov, et al.
Journal of the American College of Cardiology|July 6, 2004
The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenonJohn F Beltrame, Stuart P Turner, Sue L Leslie, et al.
Journal of Cardiovascular Pharmacology|November 25, 2005
Dissociation between metabolic and efficiency effects of perhexiline in normoxic rat myocardiumSteven A Unger, Jennifer A Kennedy, Kate McFadden-Lewis, et al.
Journal of the American Heart Association|August 20, 2014
Aging of the nitric oxide system: are we as old as our NO?Aaron L Sverdlov, Doan T M Ngo, Wai P A Chan, et al.
Pageof 22